Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : IPHA save search
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -2.4%
H: 3.69%
C: 3.28%
pharma conference year financial results
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 9.45%
H: 0.0%
C: -1.7%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -1.16%
H: 0.39%
C: -4.31%
sar4435 pharma iph6101 cell results sanofi
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 09:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 6.61%
H: 9.39%
C: 6.61%
pharma business update financial results
Innate Pharma Reports First Half 2023 Financial Results and Business Update
Published: 2023-09-14 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.14%
H: 0.0%
C: -1.3%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.26%
H: 0.74%
C: 0.33%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -5.23%
H: 6.9%
C: 5.74%
pharma business update financial results
Innate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria
Published: 2023-06-16 (Crawled : 10:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.42%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 1.84%
H: 6.63%
C: 4.82%
pharma results study phase 2
Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
Published: 2023-05-10 (Crawled : 09:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -2.46%
H: 2.18%
C: -1.34%
pharma business update financial results
Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
Published: 2023-03-23 (Crawled : 08:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: 0.52%
H: 0.0%
C: -3.23%
BNPQY | $34.25 -2.68% 180K
|
Finance and Insurance
|
| O: 1.88%
H: 0.14%
C: -3.52%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 5.54%
H: 0.96%
C: 0.96%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 6.53%
H: 0.56%
C: -0.54%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: -11.3%
pharma business year update financial results
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published: 2022-11-04 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.25%
H: 0.11%
C: -1.03%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.27%
H: 8.9%
C: 6.93%
pharma trial results platform
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
pharma report financial update results
Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published: 2022-09-15 (Crawled : 06:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: -1.65%
H: 0.0%
C: -2.85%
BNPQY | $34.25 -2.68% 180K
|
Finance and Insurance
|
| O: -1.12%
H: 2.34%
C: 1.69%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.88%
H: 0.45%
C: -0.87%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 3.25%
H: 0.0%
C: 0.0%
pharma financial update results
Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
Published: 2022-05-10 (Crawled : 07:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -0.37%
H: 2.23%
C: 0.93%
pharma results
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
BNPQY | $34.25 -2.68% 180K
|
Finance and Insurance
|
| O: -0.98%
H: 1.17%
C: 0.78%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.27%
H: 0.98%
C: 0.93%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.17%
results pharma
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 1.51%
H: 2.38%
C: 2.08%
financial results conference results pharma
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Published: 2021-09-15 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.32%
H: 0.05%
C: -0.08%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: -0.55%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 11.15%
H: 0.48%
C: -8.22%
financial results results pharma
Innate Pharma reports Full Year 2020 financial results and business update
Published: 2021-03-18 (Crawled : 07:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.43%
H: 0.99%
C: 0.23%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.43%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.27%
H: 1.16%
C: 1.16%
financial results results pharma
Innate Pharma Reports Full Year 2020 Financial(1) Results and Business Update
Published: 2021-03-18 (Crawled : 07:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.43%
H: 0.99%
C: 0.23%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.43%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.27%
H: 1.16%
C: 1.16%
results pharma
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
Published: 2021-03-16 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: 0.78%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.27%
H: 1.17%
C: 1.15%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.0%
H: 1.06%
C: 0.85%
financial results results conference pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.